Back to MACQUARIE GROUP LTD MACQUARIE GROUP LTD

MRTXMRTX
22 quarters

Position history for MACQUARIE GROUP LTDMACQUARIE GROUP LTD's holdings in MIRATI THERAPEUTICS INC

As of its Q4 2023 13F, Macquarie Group held 60,000 shares of MRTX (Mirati Therapeutics), worth $3.5M. Macquarie Group's 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$9.5M

Total Shares Change

-223,630

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Unchanged
60,000
0.0%
$3.5M0.0%—
0
2023-Q3
Unchanged
60,000
0.0%
$2.6M0.0%—
0
2023-Q2
Unchanged
60,000
0.0%
$2.2M0.0%—
0
2023-Q1
Unchanged
60,000
0.0%
$2.2M0.0%—
0
2022-Q4
Decreased
60,000
-1.1%
$2.7M0.0%—
0
2022-Q3
Decreased
60,638
-0.7%
$4.3M0.0%—
0
2022-Q2
Decreased
61,055
-12.9%
$4.1M0.0%—
0
2022-Q1
Increased
70,098
+0.4%
$5.8M0.0%—
27
2021-Q4
Increased
69,810
+0.3%
$10.2M0.0%—
28
2021-Q3
Decreased
69,598
-3.8%
$12.3M0.0%—
0
2021-Q2
Decreased
72,323
-11.6%
$11.7M0.0%—
0
2021-Q1
Decreased
81,774
-13.0%
$14M0.0%—
0
2020-Q4
Decreased
94,008
-21.5%
$20.6M0.0%—
0
2020-Q3
Decreased
119,795
-35.3%
$19.9M0.0%—
0
2020-Q2
Increased
185,171
+3.9%
$21.1M0.0%—
30
2020-Q1
Unchanged
178,271
0.0%
$13.7M0.0%—
0
2019-Q4
Decreased
178,271
-24.4%
$23M0.0%—
0
2019-Q3
Increased
235,930
+5.5%
$18.4M0.0%—
30
2019-Q2
Unchanged
223,630
0.0%
$23M0.0%—
0
2019-Q1
Unchanged
223,630
0.0%
$16.4M0.0%—
0
2018-Q4
First report
223,630
-
$9.5M0.0%—
0

Other major holders of MRTX: Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used